Member LoginMember Login - User registration - Setup as front page - Add to favorites - Sitemap Senate passes reauthorization of key US surveillance program !

Senate passes reauthorization of key US surveillance program

Time:2024-04-20 18:53:45 source:Worldly Wisdom news portal

WASHINGTON (AP) — After its midnight deadline, the Senate voted early Saturday to reauthorize a key U.S. surveillance law after divisions over whether the FBI should be restricted from using the program to search for Americans’ data nearly forced the statute to lapse.

The legislation approved 60-34 with bipartisan support would extend for two years the program known as Section 702 of the Foreign Intelligence Surveillance Act. It now goes to President Joe Biden’s desk to become law. White House national security adviser Jake Sullivan said Biden “will swiftly sign the bill.”

“In the nick of time, we are reauthorizing FISA right before it expires at midnight,” Senate Majority Leader Chuck Schumer said when voting on final passage began 15 minutes before the deadline. “All day long, we persisted and we persisted in trying to reach a breakthrough and in the end, we have succeeded.”

Related information
  • Taylor Swift's ex Joe Alwyn wanted to keep their six year relationship 'personal'
  • Free Daycare Services for Students Provided in Hefei
  • 2022 China New Media Conference Kicks off in Changsha
  • China to Have over 1,000 National Water Parks by 2025
  • Teen fighter pauses near Myawaddy to talk of decision to join resistance — Radio Free Asia
  • Hezhe People Enjoy Colorful Life in Heilongjiang, NE China
  • China to Improve Sci
  • Fruit Planting Helps Improve Environment and Villagers' Income in SW China's Chongqing
Recommended content
  • Where will Israel
  • Government Striving to Improve Nursery Services to Boost Birth Rate
  • County in China's Shaanxi Transforms Ecological Resources to Green Economy
  • Freshmen Come to Register at Peking University
  • Ukraine, Israel aid bill on track as House pushes toward votes
  • China's First Domestic HPV Vaccine Shows 100 Pct Efficacy in Clinical Trial